A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy
Condition(s):Metastatic Pancreatic Ductal AdenocarcinomaLast Updated:January 11, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Pancreatic Ductal AdenocarcinomaLast Updated:January 11, 2022Terminated
Condition(s):Locally Advanced Pancreatic Ductal Adenocarcinoma; Metastatic Pancreatic Ductal Adenocarcinoma; Stage II Pancreatic Cancer AJCC v8; Stage IIA Pancreatic Cancer AJCC v8; Stage IIB Pancreatic Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8; Unresectable Pancreatic Ductal AdenocarcinomaLast Updated:March 13, 2024Recruiting
Condition(s):ICC; Metastatic CancerLast Updated:February 4, 2021Withdrawn
Condition(s):Rectum CancerLast Updated:April 22, 2015Completed
Condition(s):Pancreatic Adenocarcinoma Metastatic; Chemotherapy EffectLast Updated:August 22, 2018Recruiting
Condition(s):Colorectal Cancer MetastaticLast Updated:December 18, 2013Unknown status
Condition(s):Rectal CancerLast Updated:June 3, 2011Completed
Condition(s):Pancreatic Cancer; Pancreatic Carcinoma Non-resectable; Locally Advanced Malignant NeoplasmLast Updated:May 28, 2020Terminated
Condition(s):Stage III Pancreatic CancerLast Updated:November 25, 2022Recruiting
Condition(s):Locally Advanced Rectal CancerLast Updated:March 23, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.